CTLA4 and cancer: Although the number of cancer patients who pass away each year continues to rise, there has been a notable improvement in the treatment of various cancers through the use of immune checkpoint inhibitors like cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein-1 (PD-1).